Courtesy of Stratagene Until now, the high cost of quantitative PCR (QPCR) instruments has limited access to the technology mostly to core facilities and industrial settings. Individual labs wanting ...

NEW YORK (MarketWatch) -- Strategene Corp. said a Wisconsin judge has awarded Third Wave Technologies $15.9 million in damages and ruled that Stratagene must pay Third Wave's legal fees in a ...

LONDON (MarketWatch) -- Strategene Corp. posted first-quarter net income that rose to $2.9 million, or 13 cents a share, from $2.1 million, or 13 cents a share, in the year earlier quarter ...